17 May | 12:15 -13:15 CEST | Room 252B
Moderator : Roberto Garbo
Anchorperson: Dariusz Dudek
Speakers: Nieves Gonzalo, Javier Escaned, Ajay J Kirtane, Abdul Mozid
16 May | 13:45-14:30 CEST | Studio A
Moderator : Rasha Al-Lamee
Anchorperson: Nieves Gonzalo
Speakers: Matthias Götberg, Javier Escaned, Eric Van Belle
Tuesday 16 May – 12:00-13:30 – Room Maillot Dynamic coronary roadmap for contrast reduction trial, Javier Escaned Thursday 18 May – 15:15-16:45 – Room Maillot
iFR vs. FFR-guided revascularisation decision-making in left main disease,
DEFINE-FLAIR: five-year follow-up, Javier Escaned
Tuesday 16 May – 12:00-13:30 – Room Maillot
Dynamic coronary roadmap for contrast reduction trial, Javier Escaned
Thursday 18 May – 15:15-16:45 – Room Maillot
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
In-depth research identified a number of critical factors that could successfully address challenges in the care pathway.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
Dynamic Coronary Roadmap, a Philips-exclusive technology, creates a motion-compensated, real-time view of coronary arteries. A highlighted coronary angiogram is superimposed on a live 2D fluoroscopic image, creating a colored roadmap that adjusts automatically, providing continuous visual feedback on positioning of wires and catheters.
Philips Interventional Hemodynamic system (Hemo system) brings advanced hemodynamic measurements to the cath lab to support clinical decision making. Integrated with the state-of-the-art IntelliVue X3 patient monitor and Azurion, this system helps further simplify your cath lab workflow.
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Coronary diagnostic for Complex PCI
Joost Maltha Joost.email@example.com Philips Global Press Office Tel: +31 6 10 55 8116
Philips Global Press Office
Tel: +31 6 10 55 8116
We are always interested in engaging with you.
Let us know how we can help.
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
You are about to visit a Philips global content pageContinue
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.